ARC Ventures: Investment Portfolio & Startup News

Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

Neobe Therapeutics is developing engineered bacteria that break down the physical barriers keeping cancer drugs and immune cells out of solid tumours. The bacteria are harmless strains of common bacteria that travel to tumours once injected and release enzymes that dissolve the surrounding matrix.